Amyotrophie spinale type 1 : enquête multicentrique des pratiques de soins et d’accompagnement palliatif sur deux périodes successives de 10ans-Reference-Cited by-同舟云学术

Amyotrophie spinale type 1 : enquête multicentrique des pratiques de soins et d’accompagnement palliatif sur deux périodes successives de 10ans

Published:2014-04 Issue:4 Volume:21 Page:347-354
ISSN:0929-693X
Container-title:Archives de Pédiatrie
language:fr
Short-container-title:Archives de Pédiatrie

Author:

Barnérias C.,Quijano S.,Mayer M.,Estournet B.,Cuisset J.-M.,Sukno S.,Peudenier S.,Laroche C.,Chabrier S.,Sabouraud P.,Vuillerot C.,Chabrol B.,Halbert C.,Cancès C.,Beze-Beyrie P.,Ledivenah A.,Viallard M.-L.,Desguerre I.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference26 articles.

1. Apports possibles d’une équipe mobile d’accompagnement et de soins palliatifs dans les situations de limitation et d’arrêt de traitement actif;Viallard;Med Palliat,2009

2. Participants of the International Conference on SMA Standard of Care Consensus statement for standard of care in spinal muscular atrophy;Wang;J Child Neurol,2007

3. Genotype–phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany : implications for clinical trials and genetic counselling;Rudnik-Schöneborn;Clin Genet,2009

4. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications;Zerres;Arch Neurol,1995

5. Spinal muscular atrophy. A 4 years prospective, multicenter, longitudinal study (168 cases);Barois;Bull Acad Natl Med,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motor and neurocognitive profiles of children with symptomatic spinal muscular atrophy type 1 with two copies of SMN2 before and after treatment: a longitudinal observational study;Frontiers in Neurology;2024-02-21

2. Interim Analysis of Treatment Outcomes of Young Children with 5q Spinal Muscular Atrophy on Gene Replacement Therapy with Onasemnogene Abeparvovec. Clinical Observations;Current Pediatrics;2023-01-20

3. Nouvelles thérapeutiques dans le champ des maladies neuromusculaires : quels enjeux ?;Handicap et génétique;2020-11-12

4. Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study;Orphanet Journal of Rare Diseases;2020-06-12

5. Population-based analysis of survival in spinal muscular atrophy;Neurology;2020-03-26